Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study.Idanna Innocenti,Gianluigi Reda, Andrea Visentin,Marta Coscia, Marina Motta,Roberta Murru,Riccardo Moia, Massimo Gentile,Elsa Pennese, Francesca Maria Quaglia,Francesco Albano, Ramona Cassin,Marina Deodato,Claudia Ielo, Anna Maria Frustaci,Alfonso Piciocchi,Arianna Rughini,Valentina Arena, Daniela Di Sevo, Annamaria Tomasso,Francesco Autore,Giovanni Del Poeta, Lydia Scarfò,Francesca Romana Mauro, Alessandra Tedeschi,Livio Trentin, Maurizio Pompili,Robin Foà, Paolo Ghia,Antonio Cuneo,Luca LaurentiHaematologica(2022)引用 9|浏览27暂无评分摘要Not available.更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要